Abstract
This study aimed to investigate whether inhibition of endoplasmic reticulum stress (ERS) mediated the ameliorative effect of apelin on acute heart failure (AHF). Rabbit model of AHF was induced by sodium pentobarbital. Cardiac dysfunction and injury were detected in the rabbit models of AHF, including impaired hemodynamic parameters and increased levels of CK-MB and cTnI. Apelin treatment dramatically improved cardiac impairment caused by AHF. ERS, indexed by increased GRP78, CHOP, and cleaved-caspase12 protein levels, was simultaneously attenuated by apelin. Apelin also could ameliorate increased protein levels of cleaved-caspase3 and Bax, and improved decreased protein levels of Bcl-2. Two common ERS stimulators, tunicamycin (Tm) and dithiothreitol (DTT) blocked the ameliorative effect of apelin on AHF. Phosphorylated Akt levels increased after apelin treatment in the rabbit models of AHF. The Akt signaling inhibitors wortmannin and LY294002 could block the cardioprotective effect of apelin, which could be relieved by ERS inhibitor 4-phenyl butyric acid (4-PBA). The aforementioned beneficial effects of apelin could all be blocked by APJ receptor antagonist F13A. 4-PBA and SC79, an Akt activator, can restore the ameliorative effect of apelin on AHF blocked by F13A. Apelin treatment dramatically ameliorated cardiac impairment caused by AHF, which might be mediated by APJ/Akt/ERS signaling pathway. These results will shed new light on AHF therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of data and materials
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Code availability
Not applicable.
References
Abrahamsson P, Swedberg K, Borer JS, Böhm M, Kober L, Komajda M, Lloyd SM, Metra M, Tavazzi L, Ford I (2013) Risk following hospitalization in stable chronic systolic heart failure. Eur J Heart Fail 15:885–891. https://doi.org/10.1093/eurjhf/hft032
Ahmed A, Allman RM, Fonarow GC, Love TE, Zannad F, Dell’italia LJ, White M, Gheorghiade M (2008) Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail 14:211–218. https://doi.org/10.1016/j.cardfail.2007.12.001
Alousi AA, Canter JM, Montenaro MJ, Fort DJ, Ferrari RA (1983) Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals. J Cardiovasc Pharmacol 5:792–803. https://doi.org/10.1097/00005344-198309000-00014
Alousi AA, Canter JM, Fort DJ (1985) The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog. Cardiovasc Res 19:483–494. https://doi.org/10.1093/cvr/19.8.483
Ashokan A, Kameswaran M, Aradhyam GK (2019) Molecular determinants on extracellular loop domains that dictate interaction between β-arrestin and human APJ receptor. FEBS Lett 593:634–643. https://doi.org/10.1002/1873-3468.13344
Berry MF, Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner TJ, Woo YJ (2004) Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110:II187–II193. https://doi.org/10.1161/01.CIR.0000138382.57325.5c
Braunwald E (1980) Pathophysiology of heart failure. In: Braunwald E (ed) Heart disease: a textbook of cardiovascular medicine, vol 1. WB Saunders, Philadelphia, pp 453–471
Ceylan-Isik AF, Kandadi MR, Xu X, Hua Y, Chicco AJ, Ren J, Nair S (2013) Apelin administration ameliorates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J Mol Cell Cardiol 63:4–13. https://doi.org/10.1016/j.yjmcc.2013.07.002
Chen H, Zheng C, Zhang X, Li J, Li J, Zheng L, Huang K (2011) Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice. Peptides 32:1634–1639. https://doi.org/10.1016/j.peptides.2011.06.025
Daniel EE, Fulton JB, Hiddleston M, Martin W, Foulks JG (1956) An analysis of the mechanism of barbiturate induced cardiovascular depression and its antagonism by sympathomimetic amines. Am J Physiol 108:457–472
Dong M, Hu N, Hua Y, Xu X, Kandadi MR, Guo R, Jiang S, Nair S, Hu D, Ren J (2013) Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress. Biochim Biophys Acta 1832:848–863. https://doi.org/10.1016/j.bbadis.2013.02.023
Folino A, Accomasso L, Giachino C, Montarolo PG, Losano G, Pagliaro P, Rastaldo R (2018) Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src. Acta Physiol (Oxf). https://doi.org/10.1111/apha.12924
Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO (2013) Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol 61:391–403. https://doi.org/10.1016/j.jacc.2012.09.038
Griffiths PR, Lolait SJ, Harris LE, Paton JFR, O’Carroll AM (2017) Vasopressin V1a receptors mediate the hypertensive effects of [Pyr1] apelin-13 in the rat rostral ventrolateral medulla. J Physiol 595:3303–3318. https://doi.org/10.1113/JP274178
Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma S, Kitada C, Nishizawa N, Murosaki S, Kurokawa T, Onda H, Tatemoto K, Fujino M (1999) Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1452:25–35. https://doi.org/10.1016/s0167-4889(99)00114-7
Hashimoto Y, Ishida J, Yamamoto R, Fujiwara K, Asada S, Kasuya Y, Mochizuki N, Fukamizu A (2005) G protein-coupled APJ receptor signaling induces focal adhesion formation and cell motility. Int J Mol Med 16:787–792
He L, Zhou Q, Huang Z, Xu J, Zhou H, Lv D, Lu L, Huang S, Tang M, Zhong J, Chen JX, Luo X, Li L, Chen L (2019) PINK1/Parkin-mediated mitophagy promotes apelin-13-induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions. J Cell Physiol 234:8668–8682. https://doi.org/10.1002/jcp.27527
Japp AG, Cruden NL, Barnes G, van Gemeren N, Mathews J, Adamson J, Johnston NR, Denvir MA, Megson IL, Flapan AD, Newby DE (2010) Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation 121:1818–1827. https://doi.org/10.1161/CIRCULATIONAHA.109.911339
Koguchi W, Kobayashi N, Takeshima H, Ishikawa M, Sugiyama F, Ishimitsu T (2012) Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure. Circ J 76:137–144. https://doi.org/10.1253/circj.cj-11-0689
Kristensen SL, Jhund PS, Køber L, Preiss D, Kjekshus J, McKelvie RS, Zile MR, Anand IS, Wikstrand J, Wedel H, Komajda M, Carson PE, Cleland JG, McMurray JJ (2015) Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. Eur J Heart Fail 17:169–176. https://doi.org/10.1002/ejhf.211
Kuba K, Zhang L, Imai Y, Arab S, Chen M, Maekawa Y, Leschnik M, Leibbrandt A, Markovic M, Schwaighofer J, Beetz N, Musialek R, Neely GG, Komnenovic V, Kolm U, Metzler B, Ricci R, Hara H, Meixner A, Nghiem M, Chen X, Dawood F, Wong KM, Sarao R, Cukerman E, Kimura A, Hein L, Thalhammer J, Liu PP, Penninger JM (2007) Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ Res 101:e32-42. https://doi.org/10.1161/CIRCRESAHA.107.158659
Lee R, Xu B, Rame JE, Felkin LE, Barton P, Dries DL (2014) Regulated inositol-requiring protein 1-dependent decay as a mechanism of corin RNA and protein deficiency in advanced human systolic heart failure. J Am Heart Assoc 3:e001104. https://doi.org/10.1161/JAHA.114.001104
Li L, Zeng H, Chen JX (2012) Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Circ Physiol 303:H605–H618. https://doi.org/10.1152/ajpheart.00366.2012
Liu Y, Wang J, Qi SY, Ru LS, Ding C, Wang HJ, Zhao JS, Li JJ, Li AY, Wang DM (2014) Reduced endoplasmic reticulum stress might alter the course of heart failure via caspase-12 and JNK pathways. Can J Cardiol 30:368–375. https://doi.org/10.1016/j.cjca.2013.11.001
Maruyama M, Kamiya J, Kaiho T, Kobari T (1988) Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts. J Cardiovasc Pharmacol 12:579–586. https://doi.org/10.1097/00005344-198811000-00012
Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, Lawrie KW, Hervieu G, Riley G, Bolaky JE, Herrity NC, Murdock P, Darker JG (2003) Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 84:1162–1172. https://doi.org/10.1046/j.1471-4159.2003.01587.x
Mentz RJ, Metra M, Cotter G, Milo O, McKendry C, Chiswell K, Davison BA, Cleland JG, Bloomfield DM, Dittrich HC, Fiuzat M, Ponikowski P, Givertz MM, Voors AA, Teerlink JR, O’Connor CM (2015) Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. Eur J Heart Fail 17:697–706. https://doi.org/10.1002/ejhf.308
Metra M, Teerlink JR, Felker GM, Greenberg BH, Filippatos G, Ponikowski P, Teichman SL, Unemori E, Voors AA, Weatherley BD, Cotter G (2010) Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study. Eur J Heart Fail 12:1130–1139. https://doi.org/10.1093/eurjhf/hfq132
Miró Ò, García Sarasola A, Fuenzalida C, Calderón S, Jacob J, Aguirre A, Wu DM, Rizzi MA, Malchair P, Haro A, Herrera S, Gil V, Martín-Sánchez FJ, Llorens P, Herrero Puente P, Bueno H, Domínguez Rodríguez A, Müller CE, Mebazaa A, Chioncel O, Alquézar-Arbé A, ICA-SEMES Research Group (2019) Departments involved during the first episode of acute heart failure and analysis of emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort. Eur J Heart Fail 21:1231–1244. https://doi.org/10.1002/ejhf.1567
O’Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy JL, Shi X, Petronis A, George SR, Nguyen T (1993) A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136:355–360. https://doi.org/10.1016/0378-1119(93)90495-o
Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T, REVIVE Heart Failure Study Group (2013) Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail 1:103–111. https://doi.org/10.1016/j.jchf.2012.12.004
Park CS, Cha H, Kwon EJ, Sreenivasaiah PK, Kim DH (2012) The chemical chaperone 4-phenylbutyric acid attenuates pressure-overload cardiac hypertrophy by alleviating endoplasmic reticulum stress. Biochem Biophys Res Commun 421:578–584. https://doi.org/10.1016/j.bbrc.2012.04.048
Qiu J, Wang X, Wu F, Wan L, Cheng B, Wu Y, Bai B (2017) Low dose of Apelin-36 attenuates ER stress-associated apoptosis in rats with ischemic stroke. Front Neurol 8:556. https://doi.org/10.3389/fneur.2017.00556
Ross J Jr, Covell JW, Sonnenblick EH (1967) The mechanics of left ventricular contraction in acute experimental cardiac failure. J Clin Invest 46:299–312. https://doi.org/10.1172/JCI105532
Sabirli R, Koseler A, Mansur N, Zeytunluoglu A, Sabirli GT, Turkcuer I, Kilic ID (2019) Predictive value of endoplasmic reticulum stress markers in low ejection fractional heart failure. Vivo 33:1581–1592. https://doi.org/10.21873/invivo
Schwarz DS, Blower MD (2016) The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci 73:79–94. https://doi.org/10.1007/s00018-015-2052-6
Siegel JH, Sonnenblick EH (1964) Quantification and prediction of myocardial failure. Arch Surgery 89:1026–1036
Smith TW, Braunwald E (1980) The management of heart failure. In: Braunwald E (ed) Heart disease: a textbook of cardiovascular medicine, vol 1. WB Saunders, Philadelphia, pp 509–570
Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA, Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116:1482–1487. https://doi.org/10.1161/CIRCULATIONAHA.107.696906
Steiger D, Yokota T, Li J, Ren S, Minamisawa S, Wang Y (2018) The serine/threonine-protein kinase/endoribonuclease IRE1α protects the heart against pressure overload-induced heart failure. J Biol Chem 293:9652–9661. https://doi.org/10.1074/jbc.RA118.003448
Tao J, Zhu W, Li Y, Xin P, Li J, Liu M, Li J, Redington AN, Wei M (2011) Apelin-13 protects the heart against ischemia-reperfusion injury through inhibition of ER-dependent apoptotic pathways in a time-dependent fashion. Am J Physiol Heart Circ Physiol 301:H1471-1486. https://doi.org/10.1152/ajpheart.00097.2011
Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251:471–476. https://doi.org/10.1006/bbrc.1998.9489
Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, Marmor A, Katz A, Grzybowski J, Unemori E, Teichman SL, Cotter G (2009) Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 373:1429–1439. https://doi.org/10.1016/S0140-6736(09)60622-X
Teng X, Song J, Zhang G, Cai Y, Yuan F, Du J, Tang C, Qi Y (2011) Inhibition of endoplasmic reticulum stress by intermedin(1–53) protects against myocardial injury through a PI3 kinase-Akt signaling pathway. J Mol Med (Berl) 89:1195–1205. https://doi.org/10.1007/s00109-011-0808-5
Ter Maaten JM, Damman K (2019) Down the road from challenges in acute heart failure trials. Eur J Heart Fail 21:1423–1425. https://doi.org/10.1002/ejhf.1571
Torre-Amione G, Milo-Cotter O, Kaluski E, Perchenet L, Kobrin I, Frey A, Rund MM, Weatherley BD, Cotter G (2009) Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome. J Card Fail 15:639–644. https://doi.org/10.1016/j.cardfail.2009.04.001
Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334:1081–1086. https://doi.org/10.1126/science.1209038
Wang M, Gupta RC, Rastogi S, Kohli S, Sabbah MS, Zhang K, Mohyi P, Hogie M, Fischer Y, Sabbah HN (2013) Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure. J Card Fail 19:509–516. https://doi.org/10.1016/j.cardfail.2013.05.004
Wu F, Qiu J, Fan Y, Zhang Q, Cheng B, Wu Y, Bai B (2018) Apelin-13 attenuates ER stress-mediated neuronal apoptosis by activating Gαi/Gαq-CK2 signaling in ischemic stroke. Exp Neurol 302:136–144. https://doi.org/10.1016/j.expneurol.2018.01.006
Xu W, Gao L, Li T, Zheng J, Shao A, Zhang J (2018) Apelin-13 alleviates early brain injury after subarachnoid hemorrhage via suppression of endoplasmic reticulum stress-mediated apoptosis and blood–brain barrier disruption: possible involvement of ATF6/CHOP pathway. Neuroscience 388:284–296. https://doi.org/10.1016/j.neuroscience.2018.07.023
Zhang K (2015) Endoplasmic reticulum stress response and transcriptional reprogramming. Front Genet 5:460. https://doi.org/10.3389/fgene.2014.00460
Zhang Y, Ren J (2011) Thapsigargin triggers cardiac contractile dysfunction via NADPH oxidase-mediated mitochondrial dysfunction: role of Akt dephosphorylation. Free Radic Biol Med 51:2172–2184. https://doi.org/10.1016/j.freeradbiomed.2011.09.005
Zhang Y, Xia Z, La Cour KH, Ren J (2011) Activation of Akt rescues endoplasmic reticulum stress-impaired murine cardiac contractile function via glycogen synthase kinase-3β-mediated suppression of mitochondrial permeation pore opening. Antioxid Redox Signal 15:2407–2424. https://doi.org/10.1089/ars.2010.3751
Zhang F, Sun HJ, Xiong XQ, Chen Q, Li YH, Kang YM, Wang JJ, Gao XY, Zhu GQ (2014) Apelin-13 and APJ in paraventricular nucleus contribute to hypertension via sympathetic activation and vasopressin release in spontaneously hypertensive rats. Acta Physiol (Oxf) 212:17–27. https://doi.org/10.1111/apha.12342
Funding
This work was supported by the National Natural Science Foundation of China (No. 81100229, 81770499), and the Province Natural Science Foundation of Hebei (No. H2016206264, H2020206350).
Author information
Authors and Affiliations
Contributions
YL: conceptualization, data curation, formal analysis, investigation, methodology, writing—original draft; HL: conceptualization, data curation, formal analysis, investigation, methodology, writing—original draft; WX: data curation, investigation, methodology; YS: data curation, investigation, methodology; CZ: data curation, investigation, methodology; YW: data curation, investigation, methodology; RY: data curation, formal analysis, project administration; SJ: data curation, formal analysis, project administration; YW: resources, supervision, validation; XW: conceptualization, data curation, formal analysis, supervision, validation, writing—review and editing; XT: conceptualization, data curation, formal analysis, funding acquisition, supervision, validation, writing—review and editing.
Corresponding authors
Ethics declarations
Conflict of interest
Not applicable.
Ethics approval
All animal procedures complied with the Animal Management Rule of the Ministry of Health, People’s Republic of China (document No. 55, 2001), and the US National Institutes of Health guide for the care and use of laboratory animals (NIH Publications No. 8023, revised 1978) and were approved by the Animal Care Committee of Hebei Medical University.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Handling Editor: E. Closs.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, Y., Lu, H., Xu, W. et al. Apelin ameliorated acute heart failure via inhibiting endoplasmic reticulum stress in rabbits. Amino Acids 53, 417–427 (2021). https://doi.org/10.1007/s00726-021-02955-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-021-02955-3